Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05848622 · ClinicalTrials.gov registry record · NA

Gait Rehabilitation to Treat FastOA

A NA study of Osteoarthritis, Knee and Knee Osteoarthritis, sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT05848622: Recruiting NA study of Osteoarthritis, Knee and Knee Osteoarthritis, sponsored by University of North Carolina, Chapel Hill.

NCT05848622 is a NA study of Osteoarthritis, Knee and Knee Osteoarthritis that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 70 participants, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05848622, a NA study of Osteoarthritis, Knee and Knee Osteoarthritis, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effects of real-time gait biofeedback delivered over a 6-week period on early markers of FastOA and conduct 6-week and 6-month follow-up assessments in anterior cruciate ligament reconstructed patients.

Primary Outcome

Participants walk on a dual-belt force-sensing treadmill for 3000 steps while vertical ground reaction forces are collected. Change score (Post-Pre) loading rate calculated as the peak of the first time derivative of the vertical ground reaction force time series curve during the first 50% of the stance phase. This will be collected at Baseline (pre-intervention) and 6 weeks posttest. An increase in vertical ground reaction force at 6 weeks from baseline indicates improved gait mechanics.

Conditions Studied

Osteoarthritis, Knee Knee Osteoarthritis Anterior Cruciate Ligament Injuries Knee Injuries Post-traumatic Osteoarthritis Gait Cartilage, Articular

Interventions

  • BEHAVIORAL Real-time gait biofeedback
  • BEHAVIORAL Sham real-time gait biofeedback

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2023-06-13
Est. Completion 2026-05
Phase NA
University of North Carolina, Chapel Hill

1,109 total trials

What NCT05848622 shows while recruiting

NCT05848622 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (86% lower).

The record links to 7 conditions, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 2 interventions - of which Real-time gait biofeedback is the first listed.

NCT05848622 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05848622 about?

NCT05848622 is a clinical study titled "Gait Rehabilitation to Treat FastOA". The purpose of this study is to determine the effects of real-time gait biofeedback delivered over a 6-week period on early markers of FastOA and conduct 6-week and 6-month follow-up assessments in anterior cruciate ligament reconstructed patients.

What is the current status of trial NCT05848622?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2023-06-13. Estimated completion is 2026-05.

What conditions does trial NCT05848622 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee, Knee Osteoarthritis, Anterior Cruciate Ligament Injuries, Knee Injuries, Post-traumatic Osteoarthritis.

What interventions are being tested in trial NCT05848622?

The interventions under investigation include: Real-time gait biofeedback (BEHAVIORAL), Sham real-time gait biofeedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT05848622?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05848622 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05848622's enrollment target sits among peer trials

70 80th of 112 higher than 33 of 112 other Osteoarthritis, Knee trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05848622

Source: ClinicalTrials.gov NCT05848622, the US trial registry maintained by the National Library of Medicine. NCT05848622 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.